EXPRESSION PATTERNS OF MULTIDRUG-RESISTANCE (MDRl), GLUTATHIONE-S-TRANSFERASE-T (GST-T) AND DNA TOPOISOMERASE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP), I1 (TOP0 11) GENES IN RENAL CELL CARCINOMAS AND NORMAL KIDNEY
暂无分享,去创建一个
Wun-Jae Kim | O. Yoshida | H. Kinoshita | S. Arao | Y. Kakehi | U. Fukumoto
[1] G. Kovacs,et al. Diagnosis and prognosis of renal-cell tumors: a molecular approach , 1995, World Journal of Urology.
[2] G. Kovacs. The value of molecular genetic analysis in the diagnosis and prognosis of renal cell tumours , 2004, World Journal of Urology.
[3] O. Yoshida,et al. Comparison of multidrug resistance gene expression levels with malignant potentials and influence of chemotherapy in urothelial cancers. , 1995, International journal of urology : official journal of the Japanese Urological Association.
[4] Wun-Jae Kim,et al. Multidrug Resistance‐associated Protein‐mediated Multidrug Resistance Modulated by Cyclosporin A in a Human Bladder Cancer Cell Line , 1995, Japanese journal of cancer research : Gann.
[5] M. Haber,et al. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma. , 1994, Cancer research.
[6] J. Buer,et al. Immunocytochemical detection of P-glycoprotein: initial expression correlates with survival in renal cell carcinoma patients. , 1994, Oncology.
[7] J. Schneider,et al. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. , 1994, Journal of the National Cancer Institute.
[8] H. Tashiro,et al. Expression of multidrug resistance gene and localization of P-glycoprotein in human primary ovarian cancer. , 1994, Cancer research.
[9] K. Kohno,et al. Enhanced expression of the DNA topoisomerase II gene in response to heat shock stress in human epidermoid cancer KB cells. , 1993, Cancer research.
[10] L. Füzesi,et al. Collecting duct carcinoma: cytogenetic characterization , 1992, Histopathology.
[11] R. McMahon,et al. Renal carcinoma in patients undergoing nephrectomy: analysis of survival and prognostic factors. , 1992, British journal of urology.
[12] M. Volm,et al. Immunohistochemical detection of P glycoprotein, glutathione S transferase and DNA topoisomerase II in human tumors. , 1992, Oncology.
[13] J. Kuszak,et al. Relationship of the expression of the multidrug resistance gene product (P-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis. , 1991, Cancer research.
[14] A. Gazdar,et al. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[15] S. de Jong,et al. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. , 1990, Cancer research.
[16] I. Pastan,et al. Heat shock and arsenite increase expression of the multidrug resistance (MDR1) gene in human renal carcinoma cells. , 1990, The Journal of biological chemistry.
[17] I. Pastan,et al. The multidrug transporter, a double-edged sword. , 1988, The Journal of biological chemistry.
[18] T. Rushmore,et al. Carcinogen-induced mdr overexpression is associated with xenobiotic resistance in rat preneoplastic liver nodules and hepatocellular carcinomas. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[19] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[20] A. Tulpule,et al. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. , 1986, The Journal of biological chemistry.